LGND
Ligand Pharmaceuticals Incorporated
$179.35
+$1.62(+0.91%)
57
Overall
40
Value
63
Tech
68
Quality
Market Cap
$3.26B
Volume
39.17K
52W Range
$93.58 - $186.40
Target Price
$184.29
Key Metrics Overview
| Market Cap | $3.26B | P/E Ratio | 578.55 |
| 52W High | $186.40 | 52W Low | $93.58 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -28.1% | 52W Position | 92.4% |
| Overall Score | 57 | Value Score | 40 |
| Quality Score | 68 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $0.31 | EPS Next Est | $4.66 |
| EPS Growth Est | +1403.2% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $179.35 | +0.9% | 39.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW